Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · BILL · 115th Congress · H.R. 6 (EAS) — IOpioid Crisis Response Act1001.DefinitionsIn this title—(1)the terms Indian Tribe and tribal organization have the m... · Sec. 2205

Sec. 2205. Assessing barriers to opioid use disorder treatment

259 words·~1 min read·/bill/115/hr/6/eas/section-2205

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

The Comptroller General of the United States (in this section referred to as the Comptroller General ) shall conduct a study regarding the barriers to providing medication used in the treatment of substance use disorders under Medicaid distribution models such as the buy-and-bill model, and options for State Medicaid programs to remove or reduce such barriers. The study shall include analyses of each of the following models of distribution of substance use disorder treatment medications, particularly buprenorphine, naltrexone, and buprenorphine-naloxone combinations:
The purchasing, storage, and administration of substance use disorder treatment medications by providers. The dispensing of substance use disorder treatment medications by pharmacists. The ordering, prescribing, and obtaining substance use disorder treatment medications on demand from specialty pharmacies by providers. For each model of distribution specified in paragraph (1), the Comptroller General shall evaluate how each model presents barriers or could be used by selected State Medicaid programs to reduce the barriers related to the provision of substance use disorder treatment by examining what is known about the effects of the model of distribution on— Medicaid beneficiaries’ access to substance use disorder treatment medications; the differential cost to the program between each distribution model for medication assisted treatment; and provider willingness to provide or prescribe substance use disorder treatment medications.
Not later than 15 months after the date of the enactment of this Act, the Comptroller General shall submit to Congress a report containing the results of the study conducted under subsection (a), together with recommendations for such legislation and administrative action as the Comptroller General determines appropriate.
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.